REDWOOD CITY, Calif. - Codexis , Inc. (NASDAQ: NASDAQ:CDXS), a prominent player in enzymatic solutions for pharmaceutical manufacturing whose stock has surged over 50% in the past year, announced ...

Biotechnology is a high-risk, high-reward landscape where innovation determines success. Yet, occasionally, a small player ...

Corteva's genetically modified Enlist platform has had wins over Bayer in recent years in gaining approval for its GMO seeds to be imported into China, which should boost Enlist's market share.

As cancer rates in the West, and globally, tack upwards due to lifestyle and environmental pollution, so does the need for ...

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...

Tax advantages offered by PEA-PME and PEA are only available to French residents. *Shares of European companies with fewer than 5,000 employees and an annual revenue of less than €1.5 billion or total ...

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand DNA breaks in edited cells.

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Biotechnology is transforming the beauty industry, yet remains misunderstood – here the Covalo Data & Insights Team argues ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

The ambitious plans aim to secure medicine supply, accelerate innovation, strengthen clinical research, and reinforce IP ...